White William Richard's Form 4 filing
Ventyx Biosciences, Inc. (VTYX) · filed Jan 24, 2023
- Accession no.
- 0001209191-23-004684
- Filed
- Jan 24, 2023
- Trade date
- Jan 23, 2023
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions and 1 derivative transaction. Open-market sales total $1.17M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| White William RichardCIK 0001778739 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 23, 2023 | Common Stock | MOption exerciseAcquired | +33,353 | $6.03 | +$201,118.59 | 33,353 | Direct | |
| Jan 23, 2023 | Common Stock | SSaleDisposed | −5,048 | $34.33F2 | −$173,297.84 | 28,305 | Direct | |
| Jan 23, 2023 | Common Stock | SSaleDisposed | −21,278 | $35.01F3 | −$744,942.78 | 7,027 | Direct | |
| Jan 23, 2023 | Common Stock | SSaleDisposed | −7,027 | $35.91F4 | −$252,339.57 | 0 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 23, 2023 | Common Stock | MOption exerciseDisposed | −33,353 | $0.00 | $0 | 119,120 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
The sales price reported is the weighted average sale price for 5,048 shares sold. These shares were sold in multiple transactions at prices ranging from $33.70 to $34.695 by the reporting person. Full information regarding the number of shares sold at each separate price will be supplied upon request by Securities and Exchange Commission Staff, the Issuer or a security holder of the Issuer.
Referenced by the price of 1 transaction in Table I.
- F3
The sales price reported is the weighted average sale price for 21,278 shares sold. These shares were sold in multiple transactions at prices ranging from $34.705 to $35.7029 by the reporting person. Full information regarding the number of shares sold at each separate price will be supplied upon request by Securities and Exchange Commission Staff, the Issuer or a security holder of the Issuer.
Referenced by the price of 1 transaction in Table I.
- F4
The sales price reported is the weighted average sale price for 7,027 shares sold. These shares were sold in multiple transactions at prices ranging from $35.7054 to $36.48 by the reporting person. Full information regarding the number of shares sold at each separate price will be supplied upon request by Securities and Exchange Commission Staff, the Issuer or a security holder of the Issuer.
Referenced by the price of 1 transaction in Table I.